{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:31:31Z","timestamp":1790271091739,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13023-014-0189-2","type":"journal-article","created":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T18:02:31Z","timestamp":1417284151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Cysteamine (Lynovex\u00ae), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis"],"prefix":"10.1186","volume":"9","author":[{"given":"Cedric","family":"Charrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Kowalczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Shand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Fraser-Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derry","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"O\u2019Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,30]]},"reference":[{"key":"189_CR1","first-page":"CD006682","volume":"5","author":"A Plummer","year":"2013","unstructured":"Plummer A, Wildman M: Duration of intravenous antibiotic therapy in people with cystic fibrosis. Cochrane Database Syst Rev. 2013, 5: CD006682-","journal-title":"Cochrane Database Syst Rev"},{"key":"189_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1183\/09059180.00006512","volume":"22","author":"JM Bhatt","year":"2013","unstructured":"Bhatt JM: Treatment of pulmonary exacerbations in cystic fibrosis. Eur Respir Rev. 2013, 22: 205-216. 10.1183\/09059180.00006512.","journal-title":"Eur Respir Rev"},{"key":"189_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nrd2603","volume":"7","author":"S Storey","year":"2008","unstructured":"Storey S, Wald G: Novel agents in cystic fibrosis. Nat Rev Drug Discov. 2008, 7: 555-556. 10.1038\/nrd2603.","journal-title":"Nat Rev Drug Discov"},{"key":"189_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1183\/09059180.00003510","volume":"19","author":"R Balsamo","year":"2010","unstructured":"Balsamo R, Lanata L, Egan CG: Mucoactive drugs. Eur Respir Rev. 2010, 19: 127-133. 10.1183\/09059180.00003510.","journal-title":"Eur Respir Rev"},{"key":"189_CR5","doi-asserted-by":"crossref","unstructured":"Jones AP, Wallis C: Dornase alfa for cystic fibrosis. Cochrane Database of Systematic Reviews. 2010, Issue 3.Art.No.:CD001127. doi:10.1002\/14651858.CD001127.pub2.","DOI":"10.1002\/14651858.CD001127.pub2"},{"key":"189_CR6","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2165\/00003495-200060050-00006","volume":"60","author":"D Banerjee","year":"2000","unstructured":"Banerjee D, Stableforth D: The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?. Drugs. 2000, 60: 1053-1064. 10.2165\/00003495-200060050-00006.","journal-title":"Drugs"},{"key":"189_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/IDR.S16263","volume":"4","author":"R Sorde","year":"2011","unstructured":"Sorde R, Pahissa A, Rello J: Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis. Infect Drug Resist. 2011, 4: 31-41. 10.2147\/IDR.S16263.","journal-title":"Infect Drug Resist"},{"key":"189_CR8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1574-6976.2011.00295.x","volume":"35","author":"R Canton","year":"2011","unstructured":"Canton R, Morosini MI: Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev. 2011, 35: 977-991. 10.1111\/j.1574-6976.2011.00295.x.","journal-title":"FEMS Microbiol Rev"},{"key":"189_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","volume":"15","author":"JB Lyczak","year":"2002","unstructured":"Lyczak JB, Cannon CL, Pier GB: Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002, 15: 194-222. 10.1128\/CMR.15.2.194-222.2002.","journal-title":"Clin Microbiol Rev"},{"key":"189_CR10","unstructured":"O\u2019Neil D, Charrier C: A composition comprising an antibiotic and a dispersant or an anti-adhesive agent. PCT\/GB2011\/001721 2011.,"},{"key":"189_CR11","unstructured":"O\u2019Neil D, Mercer D, Charrier C: Inhibition of Biofilm Organisms. PCT\/GB2010\/000631 2010.,"},{"key":"189_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1042\/bj2280545","volume":"228","author":"WA Gahl","year":"1985","unstructured":"Gahl WA, Tietze F, Butler JD, Schulman JD: Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange. Biochem J. 1985, 228: 545-550.","journal-title":"Biochem J"},{"key":"189_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7326\/0003-4819-147-4-200708210-00006","volume":"147","author":"WA Gahl","year":"2007","unstructured":"Gahl WA, Balog JZ, Kleta R: Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intern Med. 2007, 147: 242-250. 10.7326\/0003-4819-147-4-200708210-00006.","journal-title":"Ann Intern Med"},{"key":"189_CR14","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1128\/IAI.73.4.2504-2514.2005","volume":"73","author":"N Hoffmann","year":"2005","unstructured":"Hoffmann N, Rasmussen TB, Jensen PO, Stub C, Hentzer M, Molin S, Ciofu O, Givskov M, Johansen HK, Hoiby N: Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect Immun. 2005, 73: 2504-2514. 10.1128\/IAI.73.4.2504-2514.2005.","journal-title":"Infect Immun"},{"key":"189_CR15","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1128\/JCM.02280-06","volume":"45","author":"E O\u2019Neill","year":"2007","unstructured":"O\u2019Neill E, Pozzi C, Houston P, Smyth D, Humphreys H, Robinson DA, O\u2019Gara JP: Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol. 2007, 45: 1379-1388. 10.1128\/JCM.02280-06.","journal-title":"J Clin Microbiol"},{"key":"189_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/gut.27.3.243","volume":"27","author":"JP Pearson","year":"1986","unstructured":"Pearson JP, Ward R, Allen A, Roberts NB, Taylor WH: Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration. Gut. 1986, 27: 243-248. 10.1136\/gut.27.3.243.","journal-title":"Gut"},{"key":"189_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/01.pas.0000159103.95360.e8","volume":"29","author":"A Handra-Luca","year":"2005","unstructured":"Handra-Luca A, Lamas G, Bertrand JC, Fouret P: MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol. 2005, 29: 881-889. 10.1097\/01.pas.0000159103.95360.e8.","journal-title":"Am J Surg Pathol"},{"key":"189_CR18","unstructured":"Book Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard - Ninth Edition; M07-A9. 2012, Clinical and Laboratory Standards Institute, Wayne, PA"},{"key":"189_CR19","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/bit.23046","volume":"108","author":"Y Yang","year":"2011","unstructured":"Yang Y, Tsifansky MD, Shin S, Lin Q, Yeo Y: Mannitol-guided delivery of Ciprofloxacin in artificial cystic fibrosis mucus model. Biotechnol Bioeng. 2011, 108: 1441-1449. 10.1002\/bit.23046.","journal-title":"Biotechnol Bioeng"},{"key":"189_CR20","volume-title":"Molecular Cloning: A Laboratory Manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Fritsch EF, Maniatic T: Molecular Cloning: A Laboratory Manual. 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York"},{"key":"189_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1365-2133.2005.06924.x","volume":"154","author":"CG Burkhart","year":"2006","unstructured":"Burkhart CG, Burkhart CN, Isham N: Synergistic antimicrobial activity by combining an allylamine with benzoyl peroxide with expanded coverage against yeast and bacterial species. Br J Dermatol. 2006, 154: 341-344. 10.1111\/j.1365-2133.2005.06924.x.","journal-title":"Br J Dermatol"},{"key":"189_CR22","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/jemt.20489","volume":"70","author":"T Sandberg","year":"2007","unstructured":"Sandberg T, Carlsson J, Ott MK: Mucin coatings suppress neutrophil adhesion to a polymeric model biomaterial. Microsc Res Tech. 2007, 70: 864-868. 10.1002\/jemt.20489.","journal-title":"Microsc Res Tech"},{"key":"189_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jac\/dkp165","volume":"64","author":"M Alipour","year":"2009","unstructured":"Alipour M, Suntres ZE, Omri A: Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J Antimicrob Chemother. 2009, 64: 317-325. 10.1093\/jac\/dkp165.","journal-title":"J Antimicrob Chemother"},{"key":"189_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1378\/chest.08-0412","volume":"135","author":"JA Voynow","year":"2009","unstructured":"Voynow JA, Rubin BK: Mucins, mucus, and sputum. Chest. 2009, 135: 505-512. 10.1378\/chest.08-0412.","journal-title":"Chest"},{"key":"189_CR25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s10096-013-1876-y","volume":"32","author":"MC Gaspar","year":"2013","unstructured":"Gaspar MC, Couet W, Olivier JC, Pais AA, Sousa JJ: Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review. Eur J Clin Microbiol Infect Dis. 2013, 32: 1231-1252. 10.1007\/s10096-013-1876-y.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"189_CR26","unstructured":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty Fourth Informational Supplement. CLSI Document M100-S24. 2014, Clinical and Laboratory Standards Institute, Wayne, PA"},{"key":"189_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0002-9610(00)00539-0","volume":"180","author":"WP English","year":"2000","unstructured":"English WP, Williams MD: Should aminoglycoside antibiotics be abandoned?. Am J Surg. 2000, 180: 512-515. 10.1016\/S0002-9610(00)00539-0. discussion 515\u2013516","journal-title":"Am J Surg"},{"key":"189_CR28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.mib.2011.08.003","volume":"14","author":"MA Fischbach","year":"2011","unstructured":"Fischbach MA: Combination therapies for combating antimicrobial resistance. Curr Opin Microbiol. 2011, 14: 519-523. 10.1016\/j.mib.2011.08.003.","journal-title":"Curr Opin Microbiol"},{"key":"189_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/jac\/dkl225","volume":"58","author":"W Stubbings","year":"2006","unstructured":"Stubbings W, Bostock J, Ingham E, Chopra I: Mechanisms of the post-antibiotic effects induced by rifampicin and gentamicin in Escherichia coli. J Antimicrob Chemother. 2006, 58: 444-448. 10.1093\/jac\/dkl225.","journal-title":"J Antimicrob Chemother"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0189-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-014-0189-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0189-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0189-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:37:50Z","timestamp":1630564670000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-014-0189-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,30]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["189"],"URL":"https:\/\/doi.org\/10.1186\/s13023-014-0189-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,30]]},"assertion":[{"value":"7 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"189"}}